High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer
- 1 January 2000
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 10 (s1) , 53-56
- https://doi.org/10.1046/j.1525-1438.2000.99512.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancerBone Marrow Transplantation, 1999
- High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results.Journal of Clinical Oncology, 1997
- High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients.Journal of Clinical Oncology, 1997
- How many more nails to seal the coffin of dose intensity?Annals of Oncology, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.Journal of Clinical Oncology, 1995
- Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.Journal of Clinical Oncology, 1995
- Chemotherapy options in ovarian carcinoma — a dose intensity perspectivePublished by Springer Nature ,1995
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.BMJ, 1991